Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intranasal drug delivery: opportunities and toxicologic challenges during drug development
Lea-Adriana Keller, Olivia M. Merkel, Andreas Popp
Drug Delivery and Translational Research (2021) Vol. 12, Iss. 4, pp. 735-757
Open Access | Times Cited: 384

Showing 1-25 of 384 citing articles:

Unlocking the promise of mRNA therapeutics
Eduarde Rohner, Ran Yang, Kylie S. Foo, et al.
Nature Biotechnology (2022) Vol. 40, Iss. 11, pp. 1586-1600
Open Access | Times Cited: 300
Chitosan: A Potential Biopolymer in Drug Delivery and Biomedical Applications
Nimeet Desai, Dhwani Rana, Sagar Salave, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1313-1313
Open Access | Times Cited: 259
Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19
Ji Hoon Ahn, JungMo Kim, Seon Pyo Hong, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 13
Open Access | Times Cited: 248
On a highway to the brain: A review on nose-to-brain drug delivery using nanoparticles
María Lina Formica, Daniel Andrés Real, Matías L. Picchio, et al.
Applied Materials Today (2022) Vol. 29, pp. 101631-101631
Open Access | Times Cited: 154
Chitosan: An overview of biological activities, derivatives, properties, and current advancements in biomedical applications
Great Iruoghene Edo, Emad͏͏͏͏͏͏͏͏͏͏͏͏͏͏͏͏͏͏͏ Yousif, Mohammed H. Al‐Mashhadani
Carbohydrate Research (2024) Vol. 542, pp. 109199-109199
Closed Access | Times Cited: 38
Pulmonary inhalation for disease treatment: Basic research and clinical translations
Bin Wang, Lin Wang, Qian Yang, et al.
Materials Today Bio (2024) Vol. 25, pp. 100966-100966
Open Access | Times Cited: 20
Engineered commensals for targeted nose-to-brain drug delivery
Haosheng Shen, Nikhil Aggarwal, Boqun Cui, et al.
Cell (2025)
Open Access | Times Cited: 7
The Pharmaceutical and Pharmacological Potential Applications of Bilosomes as Nanocarriers for Drug Delivery
D Mitrović, Dragana Zaklan, Maja Đanić, et al.
Molecules (2025) Vol. 30, Iss. 5, pp. 1181-1181
Open Access | Times Cited: 2
Recent progress in nanocarriers for direct nose to brain drug delivery
Nasr A. Emad, Bakr Ahmed, Abdulsalam Alhalmi, et al.
Journal of Drug Delivery Science and Technology (2021) Vol. 64, pp. 102642-102642
Closed Access | Times Cited: 82
Polymeric nanocarriers for nose-to-brain drug delivery in neurodegenerative diseases and neurodevelopmental disorders
Rania Awad, Avi Avital, Alejandro Sosnik
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 5, pp. 1866-1886
Open Access | Times Cited: 65
Transferrin-modified chitosan nanoparticles for targeted nose-to-brain delivery of proteins
Bettina Gabold, Friederike Adams, Sophie Brameyer, et al.
Drug Delivery and Translational Research (2022) Vol. 13, Iss. 3, pp. 822-838
Open Access | Times Cited: 52
Using the Intranasal Route to Administer Drugs to Treat Neurological and Psychiatric Illnesses: Rationale, Successes, and Future Needs
Andrew Lofts, Fahed Abu-Hijleh, Nicolette Rigg, et al.
CNS Drugs (2022) Vol. 36, Iss. 7, pp. 739-770
Open Access | Times Cited: 51
Different Methods and Formulations of Drugs and Vaccines for Nasal Administration
Junhu Tai, Mun Soo Han, Dabin Lee, et al.
Pharmaceutics (2022) Vol. 14, Iss. 5, pp. 1073-1073
Open Access | Times Cited: 45
The nose has it: Opportunities and challenges for intranasal drug administration for neurologic conditions including seizure clusters
Steve Chung, Jurriaan M. Peters, Kamil Detyniecki, et al.
Epilepsy & Behavior Reports (2022) Vol. 21, pp. 100581-100581
Open Access | Times Cited: 41
Nanotechnological Advances for Nose to Brain Delivery of Therapeutics to Improve the Parkinson Therapy
Dharmendra Kumar Khatri, Preeti Kumari, Shivraj Tonape, et al.
Current Neuropharmacology (2022) Vol. 21, Iss. 3, pp. 493-516
Open Access | Times Cited: 38
Intranasal Delivery of Darunavir-Loaded Mucoadhesive In Situ Gel: Experimental Design, In Vitro Evaluation, and Pharmacokinetic Studies
Anroop B. Nair, Sunita Chaudhary, Hiral Shah, et al.
Gels (2022) Vol. 8, Iss. 6, pp. 342-342
Open Access | Times Cited: 38
Assessing the drug delivery of ibuprofen by the assistance of metal-doped graphenes: Insights from density functional theory
Sahar Esfahani, Jafar Akbari, Somayeh Soleimani‐Amiri, et al.
Diamond and Related Materials (2023) Vol. 135, pp. 109893-109893
Closed Access | Times Cited: 34
IgY antibodies: The promising potential to overcome antibiotic resistance
Sherif A. El‐Kafrawy, Aymn T. Abbas, Christopher Oelkrug, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 32
Intranasal nanotherapeutics for brain targeting and clinical studies in Parkinson's disease
Paramita Saha‐Chaudhuri, Himanshu Kathuria, Murali Monohar Pandey
Journal of Controlled Release (2023) Vol. 358, pp. 293-318
Closed Access | Times Cited: 30
Microfluidic Synthesis of Ultrasmall Chitosan/Graphene Quantum Dots Particles for Intranasal Delivery in Alzheimer's Disease Treatment
Fariba Mohebichamkhorami, Mehrdad Faizi, Matin Mahmoudifard, et al.
Small (2023) Vol. 19, Iss. 40
Closed Access | Times Cited: 27
Nasal sprays for treating COVID-19: a scientific note
Vivek P. Chavda, Kajal Baviskar, Dixa A. Vaghela, et al.
Pharmacological Reports (2023) Vol. 75, Iss. 2, pp. 249-265
Open Access | Times Cited: 26
Extracellular Vesicles from Mesenchymal Stem Cells: Towards Novel Therapeutic Strategies for Neurodegenerative Diseases
Ermanna Turano, Ilaria Scambi, Federica Virla, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2917-2917
Open Access | Times Cited: 24
Nanoparticles Mediated the Diagnosis and Therapy of Glioblastoma: Bypass or Cross the Blood–Brain Barrier
Xiaowei Song, Haisheng Qian, Yongqiang Yu
Small (2023) Vol. 19, Iss. 45
Closed Access | Times Cited: 24
Prolactin and oxytocin: potential targets for migraine treatment
Anna K. Szewczyk, Samiye Ulutas, Tülin Aktürk, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 23
Synthesis of a Rivastigmine and Insulin Combinational Mucoadhesive Nanoparticle for Intranasal Delivery
Tahereh Jamshidnejad-Tosaramandani, Soheila Kashanian, Isaac Karimi, et al.
Polymers (2024) Vol. 16, Iss. 4, pp. 510-510
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top